Cellular models for tau filament assembly

Journal of Molecular Neuroscience

Volumn 19, Issue 3, 2002, Pages 309-316

  Ko, Li Wen ^a   DeTure, Michael ^a   Sahara, Naruhiko ^a   Chihab, Rifki ^a   Yen, Shu Hui ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Conditional transfectants; FTDP 17; Tau filaments

Indexed keywords

AMYLOID BETA PROTEIN; PROTEINASE INHIBITOR; TAU PROTEIN; TUBULIN;

ALZHEIMER DISEASE; CELL CULTURE; COGNITION; COST EFFECTIVENESS ANALYSIS; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG EFFECT; GLIOMA; HUMAN; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0036926849     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/jmn:19:3:309     Document Type: Review

References (40)

1. Admec E., Mercken M., Beermann M. L., Didier M., and Nixon R. A. (1997) Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau. Brain Res. 757, 93-101.
2. Anderton B. H., Brion J. P., Couck A. M., Davis D. R., Gallo J. M, Hanger D. P, et al. (1995) Modulation of PHF-like tau phosphorylation in cultured neurons and transfected cells. Neurobiol. Aging 16, 389-397.
3. Arawaka S., Usami M., Sahara N., Schellenberg G. D., Lee G., and Mori H. (1999) The tau mutation (val 337met) disrupts cytoskeletal networks of microtubules. NeuroReport 10, 993-997.
4. Barghorn S., Zheng-Fischhofer Q., Ackman M., Biernat J., von Bergen M., Mandekow E. M., et al. (2000) Structure, microtubule interactions, and paired helical filament aggregation by tau mutations of frontotemporal dementias. Biochemistry 39, 11,714-11,721.
5. Brandt R. (1996) The tau proteins in neuronal growth and development. Front. Biosci. 1, 118-130.
6. Davis D. R., Adnerton B. H., Brion J. P., Reynolds C. H., and Hanger D. P. (1997) Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures. J. Neurochem. 68, 1590-1597.
7. DeTure M., Ko L., Yen S., Nacharaju P., Easson C., Lewis J., et al. (2000) Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res. 853, 5-14.
8. DeTure M., Ko L., Easson C., Hutton M., and Yen S.-H. (2001) Inducible expression of wild type tau in H4 neuroglioma cells, in Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics (Iqbal K., Sisodia S. S., and Winblad B., eds.), Wiley, Chichester, pp. 6651-6660.
9. Fasulo L., Ugolini G., Visintin M., Bradbury A., Brancolini C., Verzillo V., et al. (2000) The neuronal microtubule-associated protein tau is a subtrate for caspase-3 and an effector of apotopsis. J. Neurochem. 75, 624-633.
10. Forlenza O. V., Spink J. M., Dayanandan R., Anderton B. H, Olesen O. F., and Lovestone S. (2000) Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK beta inhibition in neurons. J. Neural Transm. 107, 1201-1212.
11. Gamblin T. C., King M. E., Dawson H., Vitek M. P., Kuret J., Berry R. W., et al. (2000) In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants. Biochemistry 39, 6136-6144.
12. Greenberg S. M. and Kosik K. S. (1995) Secreted beta-APP stimulates MAP kinase and phosphorylatio of tau in neurons. Neurobiol. Aging 16, 403-407.
13. Grover A., DeTure M., Yen S.-H., and Hutton M. (2002) Effects on splicing and protein function of three mutations in codon N296 of tau in vitro. Neurosci. Lett. 323, 33-36.
14. Huang Y., Liu X. Q., Wyss-Coray T., Brecht W. T., Sanan D. A., and Mahley R. W. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like inclusions in neurons. Proc. Natl. Acad. Sci. USA 98, 8838-8843.
15. Hutton M., Lewis J., Dickson D., Yen S.-H., and McGowan E. (2001) Analysis of tauopathies with transgenic mice. Trends Mol. Med. 7, 467-470.
16. Klein C., Kramer E.-M., Cardine A.-M., Schraven B., Brandt R., and Trotter J. (2002) Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J. Neurosci. 22, 698-707.
17. Ko L., Sheu K. F., Young O., and Blass J. P. (1990a) Induction of epitopes associated with neurofibrillary tangles in clonal mouse neuroblastoma (S20Y) cells. Acta Neuropathol. 81, 30-40.
18. Ko L., Sheu K. F., Young O., Thaler H., and Blass, J. P. (1990b) Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease. Am. J. Pathol. 136, 867-879.
19. Ko L., Odawara T., and Yen S.-H. (1997) Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells. Brain Res. 760, 118-128.
20. Ko L., Rush T., Sahara N., Easson C., and Yen S.-H. (2001) A human neuronal cell culture model for tauopathy using conditional trangene expression of multiple tau isoforms. Mol. Biol. Cell 12 (Suppl.), 514a.
21. Ksiezak-Reding H., Liu W-K., Wall J. S., and Yen S.-H. (1997) Biochemical isolation and characterization of paired helical filaments, in Function and Malfunction of the Tau Proteins: Concepts and Approaches (Brandt R., Avila J., and Kosik K., eds.), Harwood Academic, London, pp. 331-362.
22. Lee V. M., Goedert M., and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
23. Leost M., Schultz L. A., Wu Y. Z., Biernat J., Mandelkow E. M., Bibb J. A., et al. (2000) Pullones are potent inhibitors of glycogen synthase kinase-3 beta and cyclin-dependent kinase 5/p25. Eur. J. Biochem. 267, 5983-5994.
24. LoPresti P. and Konat G. W. (2001) Hydrogen peroxide induces dephosphorylation of tau protein in cultured rat oligodendrocytes. Neurosci. Lett. 31, 142-144.
25. Lu M. and Kosik K. S. (2001) Competition for microtubule-binding with dual expression of tau missense and splice isoforms. Mol. Biol. Cell 12, 171-184.
26. Malchiodi-Albedi F., Petrucci T. C., Picconi B., Losi F., and Falchi M. (1997) Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons. J. Neurosci. Res. 48, 425-438.
27. Mattson M. P., Fu W., Waeg G., and Uchida K. (1997) 4-Hyroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule associated protein tau. NeuroReport 8, 2275-2281.
28. Mena R., Edwards P. C., Harrington C. R., Mukaetova-Ladinska E. B., and Wischik C. M. (1996) Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol. 91, 633-641.
29. Mookherjee P. and Johnson G. V. (2001) Tau phosphorylation during apoptosis of human SHSY5Y neuroblastoma cells. Brain Res. 921, 31-43.
30. Olivieri G., Brack C., Muller-Spahn F., Stahelin H. B., Herrmann M., Renard P., et al. (2000) Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J. Neurochem. 74, 231-236.
31. Perez M., Cuadros R., Smith M. A., Perry G., and Avila J. (2000) Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-noneal. FEBS Lett. 486, 270-274.
32. Perez M., Hernandez F., Gomez-Ramos A., Smith M., Perry G., and Avila J. (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur. J. Biochem. 269, 1484-1489.
33. Sahara N., Tomiyama T., and Mori H. J. (2000) Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: A novel action of R406W mutation. J. Neurosci. Res. 60, 380-387.
34. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., et al. (1998) Activation of tau protein kinase I/glycogen synthase kinase-3 beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31(Suppl.), 317-323.
35. Trinczek B., Ebneth A., Mandelkow E. M., and Mandelkow E. (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci. 11, 2355-2367.
36. Vincent I., Rosado M. E., and Davies P. (1994) Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau. J. Neurochem. 62, 715-723.
37. Vogelsberg-Ragaglia V., Bruce J., Richter-Landsberg C., Zhang B., Hong M., Trojanowski J. Q., et al. (2000) Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol. Biol. Cell. 11, 4093-4104.
38. Yen S.-H., Nacharaju P., Ko L., Kenessey A., and Liu W.-K. (1998) Microtubule-associated protein tau: Biochemical modifications, degradation, and Alzheimer's disease, in Handbook of the Aging Brain (Wang E. and Snyder S., eds.), Academic, San Diego, CA, pp. 180-195.
39. Yen S., Easson C., Nacharaju P., Hutton M., and Yen S.-H. (1999a) FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. FEBS Lett. 461, 91-95.
40. Yen S.-H., Hutton M., DeTure M., Ko L., and Nacharaju P. (1999b) Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17. Brain Pathol. 9, 695-705.